title: hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes.
authors: School of Physiology and Pharmacology, Medical Sciences Building, University of Bristol, University Walk, Bristol BS8 1TD, UK.
authors: Jules C
authors: JC
authors: Hancox
authors: School of Physiology and Pharmacology, University of Bristol, Bristol, UK.
authors: Dario
authors: D
authors: Melgari
authors: School of Biochemistry, University of Bristol, Bristol, UK.
authors: Christopher E
authors: CE
authors: Dempsey
authors: Department of Cardiovascular Sciences, Cardiology Group, University of Leicester, Glenfield Hospital, Leicester, UK.
authors: Kieran E
authors: KE
authors: Brack
authors: Department of Cell Physiology and Pharmacology, University of Leicester, Leicester, UK.
authors: John
authors: J
authors: Mitcheson
authors: Department of Cardiovascular Sciences, Cardiology Group, University of Leicester, Glenfield Hospital, Leicester, and National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit, Leicester, UK.
authors: G André
authors: GA
authors: Ng